[1]
Marocco, A., Stanisic, S., Fanelli, F., Damele, F. and Colivicchi, F. 2018. Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective. Global and Regional Health Technology Assessment. 5, 1 (Jul. 2018). DOI:https://doi.org/10.33393/grhta.2018.438.